Literature DB >> 23246684

5α-reductases in human physiology: an unfolding story.

Abdulmaged M Traish1.   

Abstract

OBJECTIVE: 5α-reductases are a family of isozymes expressed in a wide host of tissues including the central nervous system (CNS) and play a pivotal role in male sexual differentiation, development and physiology.
METHODS: A comprehensive literature search from 1970 to 2011 was made through PubMed and the relevant information was summarized.
RESULTS: 5α reductases convert testosterone, progesterone, deoxycorticosterone, aldosterone and corticosterone into their respective 5α-dihydro-derivatives, which serve as substrates for 3α-hydroxysteroid dehydrogenase enzymes. The latter transforms these 5α-reduced metabolites into a subclass of neuroactive steroid hormones with distinct physiological functions. The neuroactive steroid hormones modulate a multitude of functions in human physiology encompassing regulation of sexual differentiation, neuroprotection, memory enhancement, anxiety, sleep and stress, among others. In addition, 5α -reductase type 3 is also implicated in the N-glycosylation of proteins via formation of dolichol phosphate. The family of 5α-reductases was targeted for drug development to treat pathophysiological conditions, such as benign prostatic hyperplasia and androgenetic alopecia. While the clinical use of 5α-reductase inhibitors was well established, the scope and the magnitude of the adverse side effects of such drugs, especially on the CNS, is still unrecognized due to lack of knowledge of the various physiological functions of this family of enzymes, especially in the CNS.
CONCLUSION: There is an urgent need to better understand the function of 5α-reductases and the role of neuroactive steroids in human physiology in order to minimize the potential adverse side effects of inhibitors targeting 5α-reductases to treat benign prostatic hyperplasia and androgenic alopecia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246684     DOI: 10.4158/EP12108.RA

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  18 in total

Review 1.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 2.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

3.  Association of Suicidality and Depression With 5α-Reductase Inhibitors.

Authors:  Blayne Welk; Eric McArthur; Michael Ordon; Kelly K Anderson; Jade Hayward; Stephanie Dixon
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

Review 4.  Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

Authors:  Silvia Giatti; Silvia Diviccaro; Giancarlo Panzica; Roberto Cosimo Melcangi
Journal:  Endocrine       Date:  2018-04-19       Impact factor: 3.633

Review 5.  Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.

Authors:  Tea Lanišnik Rižner; Trevor M Penning
Journal:  Steroids       Date:  2013-11-01       Impact factor: 2.668

6.  The 5α-reductase inhibitor finasteride is not associated with alterations in sleep spindles in men referred for polysomnography.

Authors:  Michael R Goldstein; Jesse D Cook; David T Plante
Journal:  Hum Psychopharmacol       Date:  2015-10-23       Impact factor: 1.672

Review 7.  Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications.

Authors:  Kai Wang; Dong-Dong Fan; Song Jin; Nian-Zeng Xing; Yi-Nong Niu
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

8.  Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.

Authors:  Carla Di Loreto; Francesco La Marra; Giorgio Mazzon; Emanuele Belgrano; Carlo Trombetta; Sabina Cauci
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

9.  Evaluation of Resettin® on serum hormone levels in sedentary males.

Authors:  Mark L Anderson
Journal:  J Int Soc Sports Nutr       Date:  2014-08-23       Impact factor: 5.150

Review 10.  The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

Authors:  Abdulmaged M Traish; Ashwini Mulgaonkar; Nicholas Giordano
Journal:  Korean J Urol       Date:  2014-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.